Grade |
Treatment guidelines |
I: I-A: low-linear intersphincteric; I-B: low-linear transsphincteric (less than 1/3 of EAS involvement). |
Fistulotomy should be possible in >95% of these AF. |
II: low intersphincteric and transsphincteric AF (less than 1/3 of EAS involvement); II-A: abscess; II-B׃ multiple tracts; II-C׃ horseshoe; II-D׃ supralevator: complete intersphincteric supralevator AF; II-E: supralevator: Low transsphincteric (<1/3 EAS involvement) with intersphincteric supralevator extension. |
Fistulotomy should be possible >90% of these AF. |
III: III-A: high linear transsphincteric fistula (>1/3 EAS involvement); III-B: fistula with associated Crohn’s disease, sphincter injury, post-radiation exposure or anterior fistulae in a female. |
Fistulotomy should not be attempted. FPR or sphincter-saving procedures: LIFT, VAAFT, AFP, TROPIS, OTSC, or FiLac therapy should be done. |
IV: complex high (>1/3 EAS involvement). Transsphincteric fistula with either: IV-A: abscess; IV-B: multiple tracts; IV-C: Horseshoe. |
Fistulotomy should not be attempted. FPR or sphincter-saving procedures: LIFT, VAAFT, AFP, TROPIS, OTSC, or FiLac therapy should be done. Preferably refer these AF to a fistula expert. |
V: V-A: transsphincteric (>1/3 EAS Involvement) with intersphincteric supralevator extension; V-B: suprasphincteric fistula; V-C: extrasphincteric fistula. |
Fistulotomy should not be attempted. FPR or sphincter-saving procedures: LIFT, VAAFT, AFP, TROPIS, OTSC, or FiLac therapy should be done. Preferably refer these AF to a fistula expert. |